Oyster Point Pharma, Inc. — Operating Income by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/9bd2a760-38a5-4778-9b56-e86625391972/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $-96.7M | 2021-01-01 – 2021-12-31 | evidence 0001720725-22-000028 |
| FY 2020 | $-71.0M | 2020-01-01 – 2020-12-31 | evidence 0001720725-21-000023 |
| FY 2019 | $-47.3M | 2019-01-01 – 2019-12-31 | evidence 0001720725-20-000006 |
| FY 2018 | $-16.7M | 2018-01-01 – 2018-12-31 | evidence 0001720725-20-000006 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).